BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 2 Pharmacokinetics 2 (PHA503) calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:4109d294-269d-4389-817c-844f09865a87
DTSTAMP:20250908T182004Z
DTSTART:20251002T140000Z
DTEND:20251002T150000Z
SUMMARY:PK 3.1 Introduction to the pharmacokinetics module in year 2 and pharmacokinetic Parameter Estimations preparation
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:4917e706-f3a4-4dda-ba21-83978f5fe888
DTSTAMP:20250908T182004Z
DTSTART:20251007T090000Z
DTEND:20251007T100000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:6041b0a1-7665-4ff0-8d5a-9c834a303022
DTSTAMP:20250908T182004Z
DTSTART:20251007T100000Z
DTEND:20251007T110000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:ec13cdf2-6093-4e51-a567-c2a94e4fb61d
DTSTAMP:20250908T182004Z
DTSTART:20251007T110000Z
DTEND:20251007T120000Z
SUMMARY:PK 3.2 Parameter Estimations 1. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:d70070be-8ff8-4ebb-a6db-9d9227b8b4e5
DTSTAMP:20250908T182004Z
DTSTART:20251017T140000Z
DTEND:20251017T150000Z
SUMMARY:PK 3.3 Pre-clinical PK and animal to human predictions
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:9fda121e-1135-4845-9561-69166c38719f
DTSTAMP:20250908T182004Z
DTSTART:20251021T090000Z
DTEND:20251021T100000Z
SUMMARY:PK 3.4  Blood Brain Barrier
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:e9bb6a59-175d-4e4c-b4cd-0bc1ab97f186
DTSTAMP:20250908T182004Z
DTSTART:20251027T100000Z
DTEND:20251027T110000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:f3817403-9c5d-417c-a91d-a8c269b45da5
DTSTAMP:20250908T182004Z
DTSTART:20251027T110000Z
DTEND:20251027T120000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:8efe0a37-d6a8-4839-a37e-314ba281fb45
DTSTAMP:20250908T182004Z
DTSTART:20251027T120000Z
DTEND:20251027T130000Z
SUMMARY:PK 3.5 Parameter Estimations 2. 2 x 90 min sessions for half the students
DESCRIPTION:Module - PHA503, Person delivering - Cleodie
LOCATION:H5.1 and H5.2
END:VEVENT
BEGIN:VEVENT
UID:298c447a-8785-4b23-8cc8-d73867f2272a
DTSTAMP:20250908T182004Z
DTSTART:20251030T120000Z
DTEND:20251030T130000Z
SUMMARY:PK 3.6 Introduction to topics for Thursday PM  Joint Drug devt and PK
DESCRIPTION:Module - PHA503, Person delivering - Michael
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:8bfe3e21-4ff5-476c-a7c6-443c5d0f0300
DTSTAMP:20250908T182004Z
DTSTART:20251030T140000Z
DTEND:20251030T150000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:2ac7674c-6f25-4231-92fd-f10123e22f2f
DTSTAMP:20250908T182004Z
DTSTART:20251030T150000Z
DTEND:20251030T160000Z
SUMMARY:PK 3.7 study designs and choosing a dose at different clinical trial phases Joint PKDD session
DESCRIPTION:Module - PHA503, Person delivering - Ateeq/Toqa, external lecturer David Carlisle
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:9bd86984-74fb-4f5f-9500-9006d1798ab2
DTSTAMP:20250908T182004Z
DTSTART:20251113T100000Z
DTEND:20251113T110000Z
SUMMARY:PK and drug development assignment drop in session
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Ateeq
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:ee5d3948-3839-403f-9b3f-93efcb2cb80e
DTSTAMP:20250908T182004Z
DTSTART:20251113T110000Z
DTEND:20251113T120000Z
SUMMARY:PK 3.8 Pharmacogenomics
DESCRIPTION:Module - PHA503, Person delivering - Reya
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:878a02ac-dde7-4e47-8277-4fb8e605ee07
DTSTAMP:20250908T182004Z
DTSTART:20251113T120000Z
DTEND:20251113T130000Z
SUMMARY:PK 3.9 Bioequivalence 2
DESCRIPTION:Module - PHA503, Person delivering - Toqa
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:76b3f6af-ec97-4156-a5ef-4d19d0cbd18f
DTSTAMP:20250908T182004Z
DTSTART:20251205T140000Z
DTEND:20251205T150000Z
SUMMARY:PK 3.10 Pharmacokinetics and PD in aging and pregnancy
DESCRIPTION:Module - PHA503, Person delivering - ?Cleodie
LOCATION:Lecture theatre B
END:VEVENT
BEGIN:VEVENT
UID:2adecfad-2ade-4e57-8ba8-12e8ac1bfc5b
DTSTAMP:20250908T182004Z
DTSTART:20251208T100000Z
DTEND:20251208T110000Z
SUMMARY:PK 3.11 Pharmacokinetic Variability and Assignment Debrief
DESCRIPTION:Module - PHA503, Person delivering - Dagan, Toqa, Ateeq, Dan
LOCATION:Lecture theatre A
END:VEVENT
BEGIN:VEVENT
UID:395db201-435d-4b78-a8e5-cbf1118b4204
DTSTAMP:20250908T182004Z
DTSTART:20260108T140000Z
DTEND:20260108T150000Z
SUMMARY:PK 3.12  Introduction to PK modelling
DESCRIPTION:Module - PHA503, Person delivering - Prof. Joe Standing
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:a10e7bd1-209c-41f1-ba29-c1c9377e4c5d
DTSTAMP:20250908T182004Z
DTSTART:20260108T150000Z
DTEND:20260108T160000Z
SUMMARY:PK 3.13  Introduction to Compartmental analysis
DESCRIPTION:Module - PHA503, Person delivering - Dagan
LOCATION:
END:VEVENT
END:VCALENDAR
